Attendo AB (publ) (ATT.ST)
SEK 60.9
(0.66%)
SEK 60.9
(0.66%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 22.89 Billion SEK | 2.54% |
| 2022 | 22.32 Billion SEK | 5.93% |
| 2021 | 21.07 Billion SEK | 5.0% |
| 2020 | 20.07 Billion SEK | -0.98% |
| 2019 | 20.27 Billion SEK | 47.29% |
| 2018 | 13.76 Billion SEK | 7.5% |
| 2017 | 12.8 Billion SEK | 28.95% |
| 2016 | 9.92 Billion SEK | 6.9% |
| 2015 | 9.28 Billion SEK | -4.81% |
| 2014 | 9.75 Billion SEK | 6.89% |
| 2013 | 9.12 Billion SEK | 3.38% |
| 2012 | 8.82 Billion SEK | -1.93% |
| 2011 | 9 Billion SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 25.22 Billion SEK | 5.4% |
| 2024 Q1 | 23.93 Billion SEK | 4.53% |
| 2024 Q3 | 25 Billion SEK | -0.87% |
| 2023 FY | 22.89 Billion SEK | 2.54% |
| 2023 Q1 | 23.51 Billion SEK | 5.33% |
| 2023 Q2 | 23.97 Billion SEK | 1.97% |
| 2023 Q4 | 22.89 Billion SEK | -2.74% |
| 2023 Q3 | 23.53 Billion SEK | -1.83% |
| 2022 Q1 | 21.6 Billion SEK | 2.51% |
| 2022 FY | 22.32 Billion SEK | 5.93% |
| 2022 Q4 | 22.32 Billion SEK | 1.44% |
| 2022 Q3 | 22 Billion SEK | -0.4% |
| 2022 Q2 | 22.09 Billion SEK | 2.28% |
| 2021 FY | 21.07 Billion SEK | 5.0% |
| 2021 Q3 | 20.74 Billion SEK | -1.34% |
| 2021 Q4 | 21.07 Billion SEK | 1.59% |
| 2021 Q1 | 20.99 Billion SEK | 4.58% |
| 2021 Q2 | 21.02 Billion SEK | 0.18% |
| 2020 FY | 20.07 Billion SEK | -0.98% |
| 2020 Q2 | 21.12 Billion SEK | -4.88% |
| 2020 Q3 | 20.94 Billion SEK | -0.86% |
| 2020 Q4 | 20.07 Billion SEK | -4.17% |
| 2020 Q1 | 22.21 Billion SEK | 9.58% |
| 2019 Q3 | 19.79 Billion SEK | -1.36% |
| 2019 Q4 | 20.27 Billion SEK | 2.41% |
| 2019 Q1 | 19.59 Billion SEK | 42.37% |
| 2019 FY | 20.27 Billion SEK | 47.29% |
| 2019 Q2 | 20.06 Billion SEK | 2.41% |
| 2018 Q2 | 13.48 Billion SEK | 0.91% |
| 2018 FY | 13.76 Billion SEK | 7.5% |
| 2018 Q3 | 13.43 Billion SEK | -0.33% |
| 2018 Q1 | 13.36 Billion SEK | 4.36% |
| 2018 Q4 | 13.76 Billion SEK | 2.41% |
| 2017 Q2 | 10.4 Billion SEK | 3.04% |
| 2017 Q3 | 10.6 Billion SEK | 1.85% |
| 2017 Q4 | 12.8 Billion SEK | 20.77% |
| 2017 FY | 12.8 Billion SEK | 28.95% |
| 2017 Q1 | 10.1 Billion SEK | 1.73% |
| 2016 Q4 | 9.92 Billion SEK | 0.02% |
| 2016 Q3 | 9.92 Billion SEK | 4.5% |
| 2016 Q1 | 9.3 Billion SEK | 0.18% |
| 2016 FY | 9.92 Billion SEK | 6.9% |
| 2016 Q2 | 9.49 Billion SEK | 2.1% |
| 2015 FY | 9.28 Billion SEK | -4.81% |
| 2015 Q4 | 9.28 Billion SEK | -5.85% |
| 2015 Q3 | 9.86 Billion SEK | 0.0% |
| 2015 Q1 | - SEK | -100.0% |
| 2014 Q4 | 9.75 Billion SEK | 0.0% |
| 2014 FY | 9.75 Billion SEK | 6.89% |
| 2013 FY | 9.12 Billion SEK | 3.38% |
| 2012 FY | 8.82 Billion SEK | -1.93% |
| 2011 FY | 9 Billion SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ambea AB (publ) | 17.89 Billion SEK | -27.944% |
| Humana AB (publ) | 10.02 Billion SEK | -128.268% |
| ProstaLund AB (publ) | 65.5 Million SEK | -34847.41% |